JACLIN SEEBERG: Open Payments
NPI 1376141671 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 45 payments from 14 companies in 2025. Trend: 2023 $1,256 · 2024 $1,035 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $195 |
| PFIZER INC. | 8 | $136 |
| Amgen Inc. | 6 | $106 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Novo Nordisk Inc | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| LeMaitre Vascular, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| United Therapeutics Corporation | 1 | $26 |
| BridgeBio Pharma, Inc. | 1 | $26 |
Products named: LEQVIO, ELIQUIS, REPATHA, VERQUVO, WAINUA, HYDRO LEMAITRE VALVULOTOME, JARDIANCE, Tyvaso.
Industry payments across ND — which companies pay providers there.
